Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that it will release its second quarter 2021 financial results on Monday, August 9, after the close of the U.S. financial markets.
August 2, 2021
· 1 min read